The US Food and Drug Administration (FDA) has approved Par Pharmaceutical Companies' abbreviated new drug application (ANDA) for fluvoxamine maleate 100mg and 150mg extended-release (ER) capsules. Fluvoxamine maleate ER capsules are ...
Tags: FDA, Drug, fluvoxamine maleate ER
Specialty pharmaceutical company Sagent Pharmaceuticals has opted for Elsevier's Gold Standard's drug information technologies, ProspectoRx and Clinical Pharmacology to access current and accurate drug data and pricing. ProspectorRx ...
Japanese chemical and pharmaceutical company Teijin has developed a water-resistant, wet-strong printing paper made with the company's ECOPET recycled polyester fiber derived from used polyethylene terephthalate (PET) bottles. According ...
Tags: chemical, pharmaceutical, Teijin, PET bottles
Target Health and LifeOnKey have own Israel-United States Binational Industrial Research and Development (BIRD) Foundation award to integrate the EMR with the electronic data capture (EDC) clinical trial database. The two-year award worth ...
Tags: Health, LifeOnKey, clinical trial
Moberg Derma has announced the discontinuation of the development of Limtop, an actinic keratosis drug, as it failed to reach the predefined efficacy target in a completed phase II trial. Moberg Derma president and CEO Peter Wolpert said ...
Tags: drug, Moberg Derma, actinic keratosis drug
Takeda Pharmaceutical Company has submitted marketing authorisation application (MAA) seeking approval from the European Medicines Agency (EMA) for its investigational, gut-selective humanized monoclonal antibody for the treatment of adults ...
Tags: Takeda, IBD Disease Drug, MAA, EMA
India-based global pharmaceutical company Dr. Reddy's Laboratories has launched Zoledronic Acid injection (4 mg/5 mL), following the approval of its abbreviated new drug application (ANDA) from the Food and Drug Administration, in the US. ...
Tags: pharmaceutical company, pharmaceutical services, pharmaceutical
Food and Drug Administration (FDA) has approved US-based pharmaceutical company Shionogi's Osphena (ospemifene) tablets for the treatment of moderate to severe dyspareunia (painful intercourse), a symptom of vulvar and vaginal atrophy ...
Tags: FDA, Dyspareunia, Medicine
Mylan Pharmaceuticals, a subsidiary of global pharmaceutical company Mylan, has launched Fenofibrate Capsules USP, 43 mg and 130 mg. Fenofibrate Capsules, which are generic equivalent to Lupin Atlantis Holdings' Antara Capsules, are ...
Tags: Mylan Pharmaceuticals, Fenofibrate Capsules, pharmaceutical company
Takeda Pharmaceutical Company has announced the approval of Helicobacter pylori Gastritis as an additional indication to eradicate Helicobacter pylori using triple therapy with proton pump inhibitor by Japan's Ministry of Health, Labour and ...
Tags: Helicobacter pylori Gastritis, Helicobacter pylori eradication
Biopharmaceutical and diagnostics company OPKO Health has acquired Brazilian pharmaceutical company Silcon Comércio, Importacao E Exportacao de Produtos Farmaceuticos e Cosmeticos. The acquisition is expected to expand OPKO's ...
Tags: OPKO Health, Silcon, Biopharmaceutical
The Osaka Prefectural Government has issued an order for corrective action concerning the manufacturing and marketing of ALINAMIN-F5 injection to Takeda Pharmaceutical Company. A violation of the Pharmaceutical Affairs Act coupled with ...
Tags: Osaka Prefectural Government, Takeda Pharmaceutical Company
Sanford-Burnham Medical Research Institute and Florida Hospital have revamped obesity research partnership with Takeda Pharmaceutical Company for the discovery of novel anti-obesity therapeutics. The extended collaboration leverages new ...
Tags: Sanford-Burnham, Florida Hospital, obesity research, Takeda
Specialty pharmaceutical company Horizon Pharma has commenced the full commercial launch of Rayos (Prednisone) delayed-release tablets for rheumatology indications, such as rheumatoid arthritis and polymyalgia rheumatica. Rayos is a ...
Tags: Horizon Pharma, Rayos, delayed-release tablets, rheumatology indications
January was a month of change for healthcare giant Abbott said a senior medical devices analyst from GlobalData who asserted that the company’s latest cardiac diagnostics product represents a pathway to growth over the next few years. ...
Tags: Abbott, Diagnostics, medical devices analyst